Floatz logo

Mifepristone

Endocrine Disease

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Small moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Endocrine Disease cohort.

Asset / SponsorPhaseRating
Hcg
Merck KGaA, Darmstadt, Germany
Phase 3BB
TESTOSTERONE UNDECYLATE
Craig Hospital
Phase 4BB
Follitropin Alpha
Merck KGaA, Darmstadt, Germany
Phase 3BB
Irinotecan
Xiaoxiang Chen
Phase 2BB
Msj-0011
Merck KGaA, Darmstadt, Germany
Phase 3BB

View all 27 →

Same molecule, other indications

Mifepristone is also rated in:

psychotic disorderDormant
BB
Indicative ·
64 / 100
View asset →
major depressive disorderDormant
B
Indicative ·
63 / 100
View asset →
Cushing syndromeDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →